Medical Interventions for Spasmodic Dysphonia and Some Related Conditions

A Systematic Review

Joseph R. Duffy, Kathryn M. Yorkston

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

This systematic review of the literature addresses the medical management of spasmodic dysphonia (SD) and some related conditions. It was carried as part of the development of practice guidelines for the Academy of Neurologic Communication Disorders and Sciences (ANCDS). A search of electronic databases (PsychINFO, MEDLINE, and CINAHL) and hand searches of relevant edited books yielded 103 intervention studies in the categories of recurrent laryngeal nerve (RLN) section (20 references), the use of botulinum toxin (Botox) injections for the management of SD (58 references), and miscellaneous interventions (25 references). A review of this literature suggests that RLN section as a treatment for adductor SD results in a substantial degree of improvement for a substantial percentage of patients, but that recurrence of SD signs and symptoms is common. Botox injection also results in a substantial degree of improvement for a substantial percentage of patients. Benefits generally last for 3 to 4 months, but reinjection is required to maintain the effect. The side effects of a weak or breathy voice and mild dysphagia last for several weeks in many patients. The effectiveness of Botox injection for abductor SD is less pronounced and occurs in a smaller percentage of patients than adductor SD. Other surgical techniques may be of benefit when Botox injection is not successful or, as an alternative to Botox injection, but evidence for their effectiveness currently is limited. Directions for future research are provided.

Original languageEnglish (US)
JournalJournal of Medical Speech-Language Pathology
Volume11
Issue number4
StatePublished - Dec 2003

Fingerprint

Dysphonia
Botulinum Toxins
Injections
Recurrent Laryngeal Nerve
Communication Disorders
Deglutition Disorders
Nervous System Diseases
Practice Guidelines
MEDLINE
Signs and Symptoms
Databases
Recurrence

ASJC Scopus subject areas

  • Neuropsychology and Physiological Psychology
  • Otorhinolaryngology
  • Rehabilitation

Cite this

Medical Interventions for Spasmodic Dysphonia and Some Related Conditions : A Systematic Review. / Duffy, Joseph R.; Yorkston, Kathryn M.

In: Journal of Medical Speech-Language Pathology, Vol. 11, No. 4, 12.2003.

Research output: Contribution to journalArticle

@article{44f4fb5c8b684b71aee70664f0067d38,
title = "Medical Interventions for Spasmodic Dysphonia and Some Related Conditions: A Systematic Review",
abstract = "This systematic review of the literature addresses the medical management of spasmodic dysphonia (SD) and some related conditions. It was carried as part of the development of practice guidelines for the Academy of Neurologic Communication Disorders and Sciences (ANCDS). A search of electronic databases (PsychINFO, MEDLINE, and CINAHL) and hand searches of relevant edited books yielded 103 intervention studies in the categories of recurrent laryngeal nerve (RLN) section (20 references), the use of botulinum toxin (Botox) injections for the management of SD (58 references), and miscellaneous interventions (25 references). A review of this literature suggests that RLN section as a treatment for adductor SD results in a substantial degree of improvement for a substantial percentage of patients, but that recurrence of SD signs and symptoms is common. Botox injection also results in a substantial degree of improvement for a substantial percentage of patients. Benefits generally last for 3 to 4 months, but reinjection is required to maintain the effect. The side effects of a weak or breathy voice and mild dysphagia last for several weeks in many patients. The effectiveness of Botox injection for abductor SD is less pronounced and occurs in a smaller percentage of patients than adductor SD. Other surgical techniques may be of benefit when Botox injection is not successful or, as an alternative to Botox injection, but evidence for their effectiveness currently is limited. Directions for future research are provided.",
author = "Duffy, {Joseph R.} and Yorkston, {Kathryn M.}",
year = "2003",
month = "12",
language = "English (US)",
volume = "11",
journal = "Journal of Medical Speech-Language Pathology",
issn = "1065-1438",
publisher = "Delmar Learning",
number = "4",

}

TY - JOUR

T1 - Medical Interventions for Spasmodic Dysphonia and Some Related Conditions

T2 - A Systematic Review

AU - Duffy, Joseph R.

AU - Yorkston, Kathryn M.

PY - 2003/12

Y1 - 2003/12

N2 - This systematic review of the literature addresses the medical management of spasmodic dysphonia (SD) and some related conditions. It was carried as part of the development of practice guidelines for the Academy of Neurologic Communication Disorders and Sciences (ANCDS). A search of electronic databases (PsychINFO, MEDLINE, and CINAHL) and hand searches of relevant edited books yielded 103 intervention studies in the categories of recurrent laryngeal nerve (RLN) section (20 references), the use of botulinum toxin (Botox) injections for the management of SD (58 references), and miscellaneous interventions (25 references). A review of this literature suggests that RLN section as a treatment for adductor SD results in a substantial degree of improvement for a substantial percentage of patients, but that recurrence of SD signs and symptoms is common. Botox injection also results in a substantial degree of improvement for a substantial percentage of patients. Benefits generally last for 3 to 4 months, but reinjection is required to maintain the effect. The side effects of a weak or breathy voice and mild dysphagia last for several weeks in many patients. The effectiveness of Botox injection for abductor SD is less pronounced and occurs in a smaller percentage of patients than adductor SD. Other surgical techniques may be of benefit when Botox injection is not successful or, as an alternative to Botox injection, but evidence for their effectiveness currently is limited. Directions for future research are provided.

AB - This systematic review of the literature addresses the medical management of spasmodic dysphonia (SD) and some related conditions. It was carried as part of the development of practice guidelines for the Academy of Neurologic Communication Disorders and Sciences (ANCDS). A search of electronic databases (PsychINFO, MEDLINE, and CINAHL) and hand searches of relevant edited books yielded 103 intervention studies in the categories of recurrent laryngeal nerve (RLN) section (20 references), the use of botulinum toxin (Botox) injections for the management of SD (58 references), and miscellaneous interventions (25 references). A review of this literature suggests that RLN section as a treatment for adductor SD results in a substantial degree of improvement for a substantial percentage of patients, but that recurrence of SD signs and symptoms is common. Botox injection also results in a substantial degree of improvement for a substantial percentage of patients. Benefits generally last for 3 to 4 months, but reinjection is required to maintain the effect. The side effects of a weak or breathy voice and mild dysphagia last for several weeks in many patients. The effectiveness of Botox injection for abductor SD is less pronounced and occurs in a smaller percentage of patients than adductor SD. Other surgical techniques may be of benefit when Botox injection is not successful or, as an alternative to Botox injection, but evidence for their effectiveness currently is limited. Directions for future research are provided.

UR - http://www.scopus.com/inward/record.url?scp=0347601935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0347601935&partnerID=8YFLogxK

M3 - Article

VL - 11

JO - Journal of Medical Speech-Language Pathology

JF - Journal of Medical Speech-Language Pathology

SN - 1065-1438

IS - 4

ER -